Post-HIV test counselling of clients of a mobile STD/HIV clinic.
The objective of the study was to determine the post-test counselling (PTC) rates for HIV-infected and uninfected individuals receiving HIV counselling and testing on a mobile STD/HIV screening clinic and to determine whether individuals at highest risk for transmitting their infection were less likely to receive PTC than those at lower risk for transmitting. Clients presenting for HIV counselling and testing were asked about their demographic characteristics, clinical history, personal risk behaviours, and partner risk factors and told to return after 14 days for results. Disease intervention specialists (DIS) attempted to locate and counsel positive clients. The PTC rate among infected and uninfected clients was 66% and 46%, respectively. There were significant differences in demographics and risk factors for those who were post-test counselled versus those who were not. Among HIV-uninfected clients, there was a positive association between PTC and drug treatment in the past three months and having engaged in sex work within the last three months. Being female was negatively associated with PTC. Among HIV-infected clients, there was a positive association between PTC and current enrollment in drug treatment. These data suggest that mobile STD/HIV screening clinics may be limited in their effectiveness by low rates of PTC.
Ellen
Jonathan M
JM
Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Park 307, 600 N Wolfe Street, Baltimore, MD 21287, USA. jellen@jhmi.edu
Liang
Thomas S
TS
Jacob
Claude A
CA
Erbelding
Emily
E
Christmyer
Carol
C
D015492:AIDS Serodiagnosis; D000328:Adult; D003153:Community Health Services; D003376:Counseling; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008952:Mobile Health Units; D012749:Sexually Transmitted Diseases / Q000188:drug therapy / Q000517:prevention & control*